Clinical trial
An Observational Study to Describe the Long-term Safety and Effectiveness of Namuscla in the Symptomatic Management of Myotonia in Adult Patients With Non-dystrophic Myotonic Disorders
NCT04616807 is registered in ClinicalTrials.gov with Lupin Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study to Describe the Long-term Safety and Effectiveness of Namuscla in the Symptomatic Management of Myotonia in Adult Patients With Non-dystrophic Myotonic Disorders
- Lead sponsor
- Lupin Ltd.
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 17, 2020
- Completion date
- January 16, 2026
- Enrollment
- 53 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.